Study: Rapid treatment boosts survival odds for stroke victims

06/18/2013 | HealthDay News · EverydayHealth.com

A study in the Journal of the American Medical Association showed that the earlier a stroke patient receives clot-dissolving drugs, the better the outcome. Researchers looked at data from more than 58,000 ischemic stroke patients. Patients treated with tissue plasminogen activators within 90 minutes of symptom onset had a 26% lower risk of death and 28% reduced risk of intracranial hemorrhage than those treated within 181 to 270 minutes, for example.

View Full Article in:

HealthDay News · EverydayHealth.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL